Increased risk of atrial fibrillation and stroke during active stages of inflammatory bowel disease: A nationwide study

Europace

Volumn 16, Issue 4, 2014, Pages 477-484

  Kristensen, Søren Lund ^a   Lindhardsen, Jesper ^a   Ahlehoff, Ole ^a,b   Erichsen, Rune ^c   Lamberts, Morten ^a   Khalid, Usman ^a   Torp Pedersen, Christian ^a,d   Nielsen, Ole Haagen ^a   Gislason, Gunnar Hilmar ^a,e,f   Hansen, Peter Riis ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b Mental Health Services CPH   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d AALBORG UNIVERSITY   (Denmark)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Atrial fibrillation; Crohn's disease; Stroke; Ulcerative colitis

Indexed keywords

BIOLOGICAL PRODUCT; CORTICOSTEROID;

ADULT; ARTICLE; BIOLOGICAL THERAPY; CARDIOMETABOLIC RISK; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE EXACERBATION; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; REMISSION; ULCERATIVE COLITIS; ATRIAL FIBRILLATION; CASE CONTROL STUDY; COLITIS, ULCERATIVE; DENMARK; DISEASE COURSE; EPIDEMIOLOGY; HOSPITALIZATION; MIDDLE AGED; REGISTER; RISK; RISK ASSESSMENT; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STROKE; TIME; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ADULT; ATRIAL FIBRILLATION; BIOLOGICAL PRODUCTS; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; DENMARK; DISEASE PROGRESSION; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; ODDS RATIO; REGISTRIES; REMISSION INDUCTION; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84893044642     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eut312     Document Type: Article

References (36)

1. Ordas I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ. Ulcerative colitis. Lancet 2012;380:1606-19
2. Baumgart DC, Sandborn WJ. Crohn's disease. Lancet 2012;380:1590-605
3. Molodecky NA, Soon IS, Rabi DM, GhaliWA, Ferris M, Chernoff G, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012;142:46-54 e42; quiz e30
4. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. JAMA 2001;285:2370-5
5. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-95
6. Libby P, Ridker PM, Hansson GK. Inflammation in atherosclerosis: From pathophysiology to practice. J Am Coll Cardiol 2009;54:2129-38
7. Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA, et al. Inflammation as a risk factor for atrial fibrillation. Circulation 2003;108:3006-10
8. Engelmann MD, Svendsen JH. Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J 2005;26:2083-92
9. IssacTT, Dokainish H, LakkisNM.Role of inflammation in initiation and perpetuation of atrial fibrillation: A systematic review of the published data. J Am Coll Cardiol 2007; 50:2021-8
10. Conen D, Ridker PM, Everett BM, TedrowUB, Rose L, CookNRet al.Amultimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women. Eur Heart J 2010;31:1730-6
11. Andersohn F,Waring M, Garbe E. Risk of ischemic stroke in patients with Crohn's disease: A population-based nested case-control study. Inflamm Bowel Dis 2010;16: 1387-92
12. Grainge MJ,West J, Card TR. Venous thromboembolism during active disease and remission in inflammatory bowel disease: A cohort study. Lancet 2010;375:657-63
13. Zitomersky NL, Verhave M, Trenor CC III. Thrombosis and inflammatory bowel disease: A call for improved awareness and prevention. Inflamm Bowel Dis 2011;17: 458-70
14. Gandhi S, Narula N, Marshall JK, Farkouh M. Are patients with inflammatory bowel disease at increased risk of coronary artery disease? Am J Med 2012;125:956-62
15. Kristensen SL, Ahlehoff O, Lindhardsen J, Erichsen R, Jensen GV, Torp-Pedersen C, et al. Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death-A Danish Nationwide Cohort Study. PLoS ONE 2013;8:e56944
16. Ha C, Magowan S, Accortt NA, Chen J, Stone CD. Risk of arterial thrombotic events in inflammatory bowel disease. Am J Gastroenterol 2009;104:1445-51
17. Kildemoes HW, Sorensen HT, Hallas J. The Danish national prescription registry. Scand J Public Health 2011;39(Suppl):38-41
18. Frost L, Vukelic Andersen L, Vestergaard P, Husted S, Mortensen LS. Trends in risk of stroke in patients with a hospital diagnosis of nonvalvular atrial fibrillation: National Cohort Study in Denmark, 1980-2002. Neuroepidemiology 2006;26:212-9
19. Krarup LH, Boysen G, Janjua H, Prescott E, Truelsen T. Validity of stroke diagnoses in a National Register of Patients. Neuroepidemiology 2007;28:150-4
20. Olesen JB, Lip GY, HansenML, Hansen PR, Tolstrup JS, Lindhardsen J, et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: Nationwide cohort study. BMJ 2011;342:d124
21. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Lancet 2007;370: 1453-7
22. DoganY, Soylu A, ErenGA, Poturoglu S, Dolapcioglu C, SonmezKet al. Evaluation of QT and P wave dispersion and mean platelet volume among inflammatory bowel disease patients. Int J Med Sci 2011;8:540-6
23. Ahlehoff O, Gislason GH, Jorgensen CH, Lindhardsen J, Charlot M, Olesen JB, et al. Psoriasis and risk of atrial fibrillation and ischaemic stroke: A Danish Nationwide Cohort Study. Eur Heart J 2012;33:2054-64
24. Lindhardsen J, Ahlehoff O, Gislason GH, Madsen OR, Olesen JB, Svendsen JH, et al. Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study. BMJ 2012;344:e1257
25. Emilsson L, Smith JG,West J, Melander O, Ludvigsson JF. Increased risk of atrial fibrillation in patients with coeliac disease: A nationwide cohort study. Eur Heart J 2011; 32:2430-7
26. Bernstein CN,Wajda A, Blanchard JF. The incidence of arterial thromboembolic diseases in inflammatory bowel disease: A population-based study. Clin Gastroenterol Hepatol 2008;6:41-5
27. Korantzopoulos P, KolettisT, Siogas K, Goudevenos J. Atrial fibrillation and electrical remodeling: The potential role of inflammation and oxidative stress. Med Sci Monit 2003;9:RA225-9
28. Bruins P, te Velthuis H, Yazdanbakhsh AP, Jansen PG, van Hardevelt FW, de Beaumont EM, et al. Activation of the complement system during and after cardiopulmonary bypass surgery: Postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 1997;96: 3542-8
29. Irving PM, Pasi KJ, Rampton DS. Thrombosis and inflammatory bowel disease. Clin Gastroenterol Hepatol 2005;3:617-28
30. Baumgart DC, Carding SR. Inflammatory bowel disease: Cause and immunobiology. Lancet 2007;369:1627-40
31. Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol 2013;13:34-45
32. Walker BR. Glucocorticoids and cardiovascular disease. Eur J Endocrinol 2007;157: 545-59
33. Christiansen CF, Christensen S, Mehnert F, Cummings SR, Chapurlat RD, SorensenHT. Glucocorticoid use and risk of atrial fibrillation or flutter: A populationbased, case-control study. Arch Intern Med 2009;169:1677-83
34. De Caterina R, Ruigomez A, Rodriguez LA. Long-Term use of anti-inflammatory drugs and risk of atrial fibrillation. Arch Intern Med 2010;170:1450-5
35. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation-developed with the special contribution of the European Heart Rhythm Association. Europace 2012;14:1385-413
36. Vind I, Riis L, Jess T, Knudsen E, Pedersen N, Elkjaer M, et al. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: A population-based study from the Danish Crohn colitis database. Am J Gastroenterol 2006;101:1274-82.